Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Akinion appoints Dr Richard Jones as CEO

He joins the biotech firm from GlaxoSmithKline

- PMLiVE

2015’s ‘premium’ prices dissuaded J&J from acquisitions, says Gorsky

More M&A activity anticipated in 2016 and beyond

- PMLiVE

Content Strategy for pharma: Maturing your approach in 2016

In this article, Consultant Adwoa Baah and Content Marketing Manager Liz Inskip take us through three things pharma can do to improve content strategy maturity within their organisations in 2016.

Blue Latitude Health

- PMLiVE

How will child public health be prioritised? by Alison Wall

Public health strategist Alison Wall stresses the importance of child public health as a commissioning responsibility.

Say Communications

Cold weather is yet to start at St James’s Winter Shelter

First shift at the St James’s Church Winter Shelter, cooking dinner for fifteen of London’s homeless, and encourages us all to consider volunteering this winter.

Say Communications

Keeping A&E usage to a minimum – the comms challenges

Say’s latest blog takes a festive trip to A&E, and reflects on the comms challenges facing this overworked department.

Say Communications

- PMLiVE

Celgene uses ‘video views’ map in arthritis awareness drive

Be Counted! campaign highlights US views of its short films

- PMLiVE

Havas honours colleague killed in Paris attacks

Christophe Foultier was a longtime Havas Health staffer

EU flag

Baxalta’s rare blood cancer drug Oncaspar approved in Europe

First EU-wide licence for the acute lymphoblastic leukaemia treatment

- PMLiVE

FDA verdict on Amgen’s Humira biosimilar due in September

Begins review the version of AbbVie's big-selling anti-inflammatory drug

- PMLiVE

Pharma trio join with top universities for new drug search

AZ, GSK and J&J join forces with Imperial, University College and Cambridge

- PMLiVE

Nobel laureate Dr Walter Gilbert joins Amylyx Pharmaceuticals

He takes up a seat on the company's board of directors

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links